Ventrus Biosciences has selected inVentiv Clinical Solutions to manage its Phase III trial with Iferanserin in development for the treatment of hemorrhoids.
The Almac Group has completed a 67,000-sq.-ft. expansion to its facility in Durham, NC, which now houses the company’s Clinical Services and Diagnostics Divisions.
The Almac Group, headquartered in Craigavon, Northern Ireland, has been named ‘Business of the Year’ by Northern Ireland’s main daily newspaper, The Belfast Telegraph in association with BMI.